Arius Research, Inc.
33Patents
10Active
33Granted
36Portfolio score
Filing activity: Oct 8, 1999 → Feb 22, 2007 · 10 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6180357A | Individualized patient-specific anti-cancer antibodies | Physics | 66 | Expired |
| US7420041B2 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Chemistry; Metallurgy | 46 | Active |
| US7420040B2 | Cytotoxicity mediation of cells evidencing surface expression of TROP-2 | Chemistry; Metallurgy | 42 | Active |
| US6657048B2 | Individualized anti-cancer antibodies | Physics | 20 | Expired |
| US7456016B2 | Cancerous disease modifying antibodies | Human Necessities | 9 | Active |
| US7189825B2 | Cancerous disease modifying antibodies | Human Necessities | 8 | Expired |
| US7442777B2 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Physics | 6 | Expired |
| US7431923B2 | Cytotoxicity mediation of cells evidencing surface expression of CD63 | Physics | 6 | Expired |
| US7393531B2 | Cytotoxicity mediation of cells evidencing surface expression of MCSP | Human Necessities | 6 | Expired |
| US7189397B2 | Cytotoxicity mediation of cells evidencing surface expression of CD44 | Human Necessities | 5 | Expired |
| US7252821B2 | Cancerous disease modifying antibodies | Human Necessities | 5 | Expired |
| US7009040B2 | Cancerous disease modifying antibodies | Human Necessities | 4 | Expired |
| US7399835B2 | Cancerous disease modifying antibodies | Human Necessities | 3 | Expired |
| US7468254B2 | Cytotoxicity mediation of cells evidencing surface expression of MCSP | Chemistry; Metallurgy | 2 | Expired |
| US7361342B2 | Cancerous disease modifying antibodies | Human Necessities | 1 | Expired |
| US6794494B1 | Cancerous disease modifying antibodies | Human Necessities | 1 | Expired |
| US7195764B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Expired |
| US7186808B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Expired |
| US7420039B2 | Individualized anti-cancer antibodies | Physics | 0 | Expired |
| US7452978B2 | Cancerous disease modifying antibodies | Chemistry; Metallurgy | 0 | Active |
| US7419792B2 | Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody | Physics | 0 | Expired |
| US7348413B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Expired |
| US7175846B2 | Cancerous disease modifying antibodies | Human Necessities | 0 | Active |
| US7247476B2 | Individualized anti-cancer antibodies | Physics | 0 | Expired |
| US7456258B2 | Cancerous disease modifying antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.